Investigation of the effect of exercise training on clinical status in infarction cardiac patients

Comparison of the effect of two different high-intensity interval training on clinical status improvement after coronary artery bypass grafting in cardiac patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200113046119N1

Enrollment

Registered

2020-04-11

Start date

2020-04-20

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease. Chronic ischemic heart disease

Interventions

Intervention 1: First intervention group: High-intensity interval training Group with Short Activity Interventions: This group will perform high-intensity interval training exercises with 15-second in

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: The age of the subjects must be between 40-80 years old-age The subjects must undergo the coronary artery bypass grafting surgery

Exclusion criteria

Exclusion criteria: There are disabling motor disorders in the patient The patient undergoes reconstructive valve surgery

Design outcomes

Primary

Measure	Time frame
Maximal aerobic power. Timepoint: Before and after the treatment. Method of measurement: Bruce treadmill test.;Heart rate variability. Timepoint: Before and after the treatment. Method of measurement: Electrocardiogram assessment of the patient.;Quality of life. Timepoint: Before and after the treatment. Method of measurement: Heart disease patient's questionnaire.;Lower extremity muscle strength. Timepoint: Before and after the treatment. Method of measurement: One repetition maximum test of the leg press.;Systolic and diastolic function of cardiac left ventricle. Timepoint: Before and after the treatment. Method of measurement: Echocardiography.	—

Measure

Time frame

Maximal aerobic power. Timepoint: Before and after the treatment. Method of measurement: Bruce treadmill test.;Heart rate variability. Timepoint: Before and after the treatment. Method of measurement: Electrocardiogram assessment of the patient.;Quality of life. Timepoint: Before and after the treatment. Method of measurement: Heart disease patient's questionnaire.;Lower extremity muscle strength. Timepoint: Before and after the treatment. Method of measurement: One repetition maximum test of the leg press.;Systolic and diastolic function of cardiac left ventricle. Timepoint: Before and after the treatment. Method of measurement: Echocardiography.

—

Secondary

Measure	Time frame
Resting heart rate of the patient. Timepoint: Before and after the treatment. Method of measurement: Polar heart rate monitoring.;Recovery heart rate of the patient. Timepoint: Before and after the treatment. Method of measurement: Polar heart rate monitoring.;Blood pressure. Timepoint: Before and after the treatment. Method of measurement: Mercury manometer.;Body composition of the patient. Timepoint: Before and after the treatment. Method of measurement: Body composition analyzer.	—

Measure

Time frame

Resting heart rate of the patient. Timepoint: Before and after the treatment. Method of measurement: Polar heart rate monitoring.;Recovery heart rate of the patient. Timepoint: Before and after the treatment. Method of measurement: Polar heart rate monitoring.;Blood pressure. Timepoint: Before and after the treatment. Method of measurement: Mercury manometer.;Body composition of the patient. Timepoint: Before and after the treatment. Method of measurement: Body composition analyzer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLobat Majidi

Hamedan University of Medical Sciences

lobat.majidi@gmail.com+98 81 3838 1740

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026